المؤلفون: Martha Nance, Izelle Labuschagne, Karen Marder, C. Herd, Mays A. El-Dairi, Scott R. Evans, A. Daley, Henry Moore, Phyllis Chua, Jody Corey-Bloom, S. Targum, Patrick Mitchell, Jody Goldstein, David Ames, Rajeev Ananda Kumar, H. Mack, Eric Molho, S. Wray, Susan R. Criswell, Carlos Singer, Ronda Clouse, Anita M.Y. Goh, Karen Anderson, Andrew Feigin, David Oakes, Jane Griffith, Peter K. Panegyres, Carr J. Vaughan, Alessandro Iannaccone, Andrew Churchyard, Leah Levi, Craig W. Ritchie, Russell L. Margolis, D. L. Lim, Nadine Yoritomo, Barbara J. Jennings, Cameron Stone, Vicki Sergo, Constance Orme, Sarah Janicki, D. Angus, K. Helles, H. D. Rosas, Ralf Reilmann, Carolyn M. Drazinic, Arthur Watts, B. Hennig, Shea Gluhm, Sharon Fekrat, Sandra K. Kostyk, Earl Ray Dorsey, M. Moscovitch-Lopatin, Mark S. LeDoux, S. Gao, R. Ranzi, N. Padron, Elise Kayson, Shannon Guyot, K. Baker, Pinky Agarwal, Clement T. Loy, Marguerite Wieler, Steven M. Hersch, Cindy Casaceli, M. Murathodizic, Julie C. Stout, Blair R. Leavitt, D. Germaine

المصدر: The Lancet. Neurology. 14(1)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Population, Trail Making Test, Placebo-controlled study, Placebo, Placebos, Huntington's disease, Double-Blind Method, Internal medicine, medicine, Humans, education, Adverse effect, education.field_of_study, business.industry, Montreal Cognitive Assessment, Clioquinol, Middle Aged, medicine.disease, Huntington Disease, Treatment Outcome, Tolerability, Female, Neurology (clinical), business, Cognition Disorders, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061c6b2c50c34a60674732abb8ba1f5c
https://pubmed.ncbi.nlm.nih.gov/25467849